经皮结构性心脏病治疗策略：关注慢性心力衰竭。
Percutaneous Strategies in Structural Heart Diseases: Focus on Chronic Heart Failure.
机构信息
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo , São Paulo , SP - Brasil.
Hospital Alemão Oswaldo Cruz , São Paulo , SP - Brasil.
出版信息
Arq Bras Cardiol. 2023 Nov;120(11):e20220496. doi: 10.36660/abc.20220496.
BACKGROUND
Central Illustration : Percutaneous Strategies in Structural Heart Diseases: Focus on Chronic Heart Failure Transcatheter devices for monitoring and treating advanced chronic heart failure patients. PA: pulmonary artery; LA: left atrium; AFR: atrial flow regulator; TASS: Transcatheter Atrial Shunt System; VNS: vagus nerve stimulation; BAT: baroreceptor activation therapy; RDN: renal sympathetic denervation; F: approval by the American regulatory agency (FDA); E: approval by the European regulatory agency (CE Mark).
BACKGROUND
Innovations in devices during the last decade contributed to enhanced diagnosis and treatment of patients with cardiac insufficiency. These tools progressively adapted to minimally invasive strategies with rapid, widespread use. The present article focuses on actual and future directions of device-related diagnosis and treatment of chronic heart failure.
背景
核心插图
结构性心脏病的经皮策略：关注慢性心力衰竭
经导管设备用于监测和治疗晚期慢性心力衰竭患者。
PA
肺动脉；LA：左心房；AFR：心房流量调节器；TASS：经导管房分流系统；VNS：迷走神经刺激；BAT：压力感受器激活疗法；RDN：肾交感神经去神经支配；F：获得美国监管机构（FDA）批准；E：获得欧洲监管机构（CE 标志）批准。
背景
在过去十年中，设备方面的创新有助于增强对心功能不全患者的诊断和治疗。这些工具逐渐适应了微创策略，应用迅速且广泛。本文主要关注与慢性心力衰竭相关的设备诊断和治疗的现有和未来方向。
Zotero 插件